Rationale: Endoscopic retrograde cholangiopancreatography (ERCP) is the treatment of choice for biliary complications in liver transplantation (LT) recipients as it is both diagnostic and therapeutic. The specific risks following ERCP among LT recipients have not been well studied.
Introduction
Biliary complications following orthotopic liver transplantation (LT), in which biliary strictures and leaks are the most common, are important causes of graft dysfunction and re-transplantation. Endoscopic retrograde cholangiopancreatography (ERCP) is the treatment of choice for biliary complications as it is both diagnostic and therapeutic. [1, 2] The reported complication rate following ERCP among the general population varies between 4% and 12%. [3] These complications include acute pancreatitis, cholangitis, perforation, and bleeding due to sphincterotomy. Among these, acute pancreatitis is the most common, whereas gastrointestinal (GI) bleeding has rarely been reported. [4] [5] [6] The specific risks following ERCP among LT recipients have not been well studied. We herein report an unusual case of GI bleeding in a patient who underwent both LT and ERCP, and reviewed the procedure-related complications of ERCP post-LT (Table 1) . [7] [8] [9] [10] [11] [12] 
Case presentation
A 56-year-old male patient with underlying severe chronic hepatitis B infection and liver failure underwent orthotopic LT, during which the hepatic arteries and portal veins were reconstructed and bile duct was duct-to-duct anastomosed. A bedside ultrasound on day 1 post-LT showed no abnormalities in the hepatic artery, portal vein, hepatic vein, or bile duct.
However, the patient's bilirubin level gradually increased from day 5 post-LT onwards. A repeat bedside ultrasound examination revealed dilatation of the intrahepatic bile duct. Magnetic resonance cholangio-pancreatography (MRCP) performed suggested the presence of dilated hepatic and intrahepatic bile ducts. Following an assessment by experienced endoscopists, we performed an ERCP on day 10 post-LT. A stricture was found on the upper segment of the common bile duct; we proceeded with an endoscopic sphincterotomy (EST), and a plastic "Christmas tree"-like biliary stent was placed (Fig. 1) . The patient's serum biochemistry gradually improved, and the total bilirubin level decreased post-ERCP (the total bilirubin and direct bilirubin levels normalized from 265 mmol/L and 178.6 mmol/L at their highest, respectively).
However, on day 13 post-ERCP, the patient developed multiple episodes of hematemesis, although his vital signs remained stable. A continuous infusion of PPI, somatostatin, and vasopressin was initiated, as well as blood transfusion. On day 15 post-ERCP, an upper GI endoscopy revealed multiple ulcers in the gastric fundus, along with mild esophageal varices, indicating that stress ulcers might have been the cause of the GI bleeding (Fig. 2) . The duodenal mucosa appeared normal.
Despite treatment, the patient developed another episode of hematemesis on day 21 post-ERCP, with a sharp decline of hemoglobin from 99 g/L to 78 g/L. At this juncture, we postulated that the bleeding might have been due to ERCP. An emergency upper GI endoscopy revealed copious amount of blood clots surrounding the stent, along with oozing of blood at the duodenal papilla ( Fig. 3 ). Considering that he was a post-LT patient, digital subtraction angiography (DSA) of the hepatic artery and superior mesenteric artery was conducted; a hepatic pseudoaneurysm (PA) measuring 11.6 mm Â 9.7 mm was detected in the left hepatic artery (Fig. 4) . Interventional embolization of the branch with PA Figure 1 . ERCP revealed a stricture in the upper segment of the common bile duct; an endoscopic sphincterotomy was performed, and a plastic stent was placed. ERCP = endoscopic retrograde cholangiopancreatography. was performed, and the patient remained free of GI bleeding for 25 days. Following this, he developed another bout of hematemesis, this time with melena. Another hepatic PA was discovered by DSA and interventional embolization was conducted for the second time. Two days later (day 57 post-LT), the patient developed bradycardia and hypotension, and spontaneous respiration stopped. Although there was some mild improvement in his vital signs following initiation of resuscitation efforts, the patient's family decided to forgo further aggressive resuscitation, and he subsequently passed away.
Discussion
ERCP is associated with several risks, including cholangitis, pancreatitis, bleeding, perforation, and, in rare cases, death. [4] [5] [6] 13, 14] Rare complications such as subcapsular hepatic hematoma have been reported in some cases. [15] A retrospective review of 11,497 ERCP procedures revealed that among 40 cases of bleeding, only 9 were severe. [4] In a meta-analysis of 21 prospective studies, the rate of post-ERCP bleeding was 1.3%, most of which were graded moderate. [3] Sphincterotomy is considered to be a high-risk procedure for post-ERCP bleeding, even though the rate of severe hemorrhage caused by sphincterotomy was less than 0.1%. [3] This suggests that severe hemorrhage post-ERCP is not very common. Unfortunately, there is lack of data regarding the occurrence time of bleeding post-ERCP, probably due to its low occurrence rate. Based on available data, post-ERCP bleeding may be immediate or delayed. In our experience, bleeding usually occurs intraoperatively or within 24 hours post-ERCP. In the present case, the patient's coagulation profile was normal following LT. With platelet transfusion, his mean platelet level was approximately 70 G/L (lowest: 47 G/L, highest: 122 G/L) during the period between ERCP and his first bleeding post-ERCP. Low platelet levels and EST may be the noteworthy risk factors for ERCP-associated bleeding in the present case.
Hepatic artery pseudoaneurysm (PA) post-LT is a potential life-threatening complication, with an incidence of approximately 2%. [1] The most common clinical manifestation of hepatic artery pseudoaneurysm is rupture with bleeding, such as GIbleeding or hemobilia or intra-abdominal hemorrhage. Local sepsis, biloma, and biliary tract infection may increase the risk of bleeding. Since it is usually difficult to treat a ruptured PA, early detection of it following LT is of great significance. Routine follow-up computed tomography (CT) or magnetic resonance imaging may help to detect PAs before they rupture, although angiography remains the gold standard for diagnosis. In our case, the PA was located in an extrahepatic artery, and the main manifestation was GI bleeding. The use of tacrolimus and biliary obstruction may contribute to the development of the PA. A CT angiography of the hepatic artery following LT (but before ERCP) showed presence of a small PA (measuring 1.9 mm Â 3.9 mm) near the liver hilum; unfortunately, we did not pay close attention to this finding then. In addition, when the patient developed hemorrhage post-ERCP, we did not consider the primary disease and possible complications of LT.
Biliary tract-related complications following LT can be successfully managed with ERCP; however, the incidence and risk factors for post-ERCP complications among patients who have undergone LT have not been well studied. Balderramo et al [1] reported that the incidence of post-ERCP complications among LT patients is similar to that among the general population. Another study which compared post-ERCP complications between 1634 LT patients and 5852 concluded that post-ERCP bleeding was more frequent in the LT patients than the nontransplanted patients (P < .05). [16] Many factors, such as biliary sphincterotomy, renal failure, repeated pancreatic injections, and immunosuppressive therapy, may increase the risk of post-ERCP complications among LT patients.
To summarize, this was an unusual case of severe GI bleeding in an LT patient who received ERCP. We had initially misdiagnosed it as ERCP-associated bleeding; a second scope demonstrated the source of bleeding to be from a hepatic PA. We would like to emphasize the rare occurrence of ERCP-associated GI bleeding; other primary causes should therefore be ruled out, especially in delayed or severe cases.
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